Intranasal foralumab, developed by biotech company ... million grant from the National Institute on Aging to study the nasal spray for Alzheimer’s, just a few months after the FDA approved ...

When delivered up the nose, the experimental antibody treatment foralumab might be able to ... might someday involve a quick sniff of a nasal spray. Researchers have found early evidence in ...

which comes in the form of a nasal spray, to target the neuroinflammatory process. When they tested the antibody – known as Foralumab – in mouse models of moderate to severe TBI, the team ...

Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, limits central nervous system damage and improves behavioral outcomes in mice ...

The study examines the monoclonal antibody Foralumab, made by Tiziana ... "We envision giving a nasal spray right there on the sidelines," said Weiner. "It isn't something we can do yet, but ...

(MENAFN- IANS) New Delhi, Feb 27 (IANS) A nasal spray being developed to target ... The team examined the monoclonal antibody Foralumab, developed by UK-based Tiziana, which has been tested ...

A new study suggests a nasal spray developed to target neuroinflammation ... The study examines the monoclonal antibody Foralumab, made by Tiziana, which has been tested in clinical trials for ...

Foralumab works by binding to the T cell receptor to modulate ... including football players with repetitive concussions. "We envision giving a nasal spray right there on the sidelines. It isn't ...